Cancer Support Programs at Rush
Cancer is not only a physical ordeal, it is also an emotional one, affecting cancer patients, their family and friends. To help address the whole person, we offer resources to help patients and their loved ones cope in this difficult time.

Clinical Trials at Rush
Rush offers a number of clinical trials of experimental cancer treatments. If we do not list trials for a particular type of cancer, please feel free to call us to discuss other treatment options. 

Tips on Seeking a Second Opinion
Many experts recommend that cancer patients consider getting another opinion — not only to confirm the diagnosis but, more important, to learn about all available treatments. Rush has prepared information to help patients start the process. This section of the site includes a video featuring Rush president and CEO Larry Goodman, MD, and other physicians discussing the importance of second opinions in cancer care. 

Prevention and Screening Services at Rush
Through genetic testing, counseling and advanced techniques for early detection, Rush helps people with a strong history of breast, ovarian, colon and other cancers. And in our state-of-the-art mammography center, we have one of the Chicago area's finest teams of radiologists dedicated to early detection of breast cancer.

National Cancer Institute
The National Cancer Institute provides a wealth of information for cancer patients and their families, including medical information about cancer types, a clinical trials search feature, screening and testing information, and resources for coping with cancer.

1-800-4-CANCER
The National Cancer Institute staffs a cancer information hotline Monday through Friday, 8 a.m. to 8 p.m. (ET). Call 1-800-4-CANCER (1-800-422-6237). English- and Spanish-speaking information specialists are available; service is for callers within the United States.

Oncolink
Cancer specialists at the University of Pennsylvania founded OncoLink in 1994 to help cancer patients, families, health care professionals and the general public get accurate cancer-related information at no charge.